Agarwal Arjun bought ORKA
October 12, 2026 · Form 4 insider transaction
Agarwal Arjun bought 8,541 shares of Oruka Therapeutics, Inc. at $12.50 per share, a transaction worth $106.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,541
Price
$12.50
Total value
$106.8K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 12, 2026
Filing dateOctober 13, 2026
Shares owned after22,760
OwnershipDirect
10b5-1 planNo
AmendedNo